Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company. It is developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of admini... Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company. It is developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations. Show more
CHASKA, Minn., July 01, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore” or the “Company”), a fully integrated contract development and manufacturing organization...
Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabinoid toxicities that include acute...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.06 | -2.64317180617 | 2.27 | 2.47 | 2.2 | 2674 | 2.23891008 | CS |
4 | 0.26 | 13.3333333333 | 1.95 | 2.96 | 1.9 | 13439 | 2.6133656 | CS |
12 | -0.53 | -19.3430656934 | 2.74 | 3.2 | 1.8 | 7568 | 2.53563333 | CS |
26 | -0.21 | -8.67768595041 | 2.42 | 3.3 | 1.8 | 6396 | 2.61163894 | CS |
52 | -0.309 | -12.2667725288 | 2.519 | 4.05 | 1.62 | 10565 | 2.50715085 | CS |
156 | -4.64 | -67.7372262774 | 6.85 | 7.885 | 1.62 | 8054 | 3.53130686 | CS |
260 | -5.17 | -70.054200542 | 7.38 | 9.33 | 1.62 | 10227 | 4.51605432 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.